Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Crixivan

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
The pharmaceutically important tetrahydro-[1,2,3]triazolopyrazine heterocyclic architecture has been synthesized via a concise… Expand
  • figure 1
  • table 2
  • table 1
  • figure 2
  • table 3
Review
2005
Review
2005
Patients with schizophrenia are at significantly increased risk for infection with human immunodeficiency virus (HIV), hepatitis… Expand
2002
2002
  • 2002
  • Corpus ID: 53004650
DESCRIPTION CRIXIVAN (indinavir sulfate) is an inhibitor of the human immunodeficiency virus (HIV) protease. CRIXIVAN Capsules… Expand
  • table 1
  • table 2
  • table 3
  • table 5
  • figure 5
2001
2001
Two studies, concerning the synthesis of original nucleoside analogs regarded as an application of heterochemistry on… Expand
  • figure 1
  • figure 2
2000
2000
Recent results from human clinical trials have established the critical role of HIV protease inhibitors in the treatment of… Expand
Highly Cited
1999
Highly Cited
1999
Indene is oxidized to mixtures of cis- and trans-indandiols and related metabolites by Pseudomonas putida and Rhodococcus sp… Expand
Review
1999
Review
1999
The new phase of North-South research collaboration was caught in a snapshot published recently in a popular weekly newsmagazine… Expand
Review
1998
Review
1998
History tells us that when given a reasonably active lead compound, medicinal chemists usually are able to increase the potency… Expand
Highly Cited
1996
Highly Cited
1996
Indinavir (IDV) (also called CRIXIVAN, MK-639, or L-735,524) is a potent and selective inhibitor of the human immunodeficiency… Expand
1996
1996
  • MMWR. Morbidity and mortality weekly report
  • 1996
  • Corpus ID: 25134566
In 1995 and 1996, the Food and Drug Administration (FDA) approved three products in the new protease inhibitor class of drugs… Expand